Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10309-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- GPRC5A,RAI3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated GPRC5A,RAI3 antibody (Cat. #10309-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: FC, IHC, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.
Spatially multicellular variability of intervertebral disc degeneration by comparative single-cell analysis.
Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5A.
TMT-based quantitative proteomic analysis of spheroid cells of endometrial cancer possessing cancer stem cell properties.
Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer.
GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
GPRC5A reduction contributes to pollutant benzo[a]pyrene injury via aggravating murine fibrosis, leading to poor prognosis of IIP patients.
Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
Ou X, Tan Y, Xie J, Yuan J, Deng X, Shao R, Song C, Cao X, Xie X, He R, Li Y, Tang H
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2024 Mar;73:101063
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2024 Mar;73:101063
Spatially multicellular variability of intervertebral disc degeneration by comparative single-cell analysis.
Lin P, Yan P, Zhu J, Huang S, Wang Z, Hu O, Jin H, Li Y, Zhang L, Zhao J, Chen L, Liu B, He J, Gan Y, Liu P
Cell proliferation 2023 Oct;56(10):e13464
Cell proliferation 2023 Oct;56(10):e13464
Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5A.
Zhao X, Stein KR, Chen V, Griffin ME, Lairson LL, Hang HC
Nature chemical biology 2023 Oct;19(10):1205-1214
Nature chemical biology 2023 Oct;19(10):1205-1214
TMT-based quantitative proteomic analysis of spheroid cells of endometrial cancer possessing cancer stem cell properties.
Cao M, Liu Z, You D, Pan Y, Zhang Q
Stem cell research & therapy 2023 May 4;14(1):119
Stem cell research & therapy 2023 May 4;14(1):119
Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer.
Chen Y, Wang J, Guo Q, Li X, Zou X
Cancers 2022 Nov 4;14(21)
Cancers 2022 Nov 4;14(21)
GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Er J, Chao L, Yiwei L, Feng X, Fei Z, Kan W, Ruifei X
Experimental lung research 2020 Sep;46(7):226-233
Experimental lung research 2020 Sep;46(7):226-233
GPRC5A reduction contributes to pollutant benzo[a]pyrene injury via aggravating murine fibrosis, leading to poor prognosis of IIP patients.
Huang Z, Wang S, Liu Y, Fan L, Zeng Y, Han H, Zhang H, Yu X, Zhang Y, Huang D, Wu Y, Jiang W, Zhu P, Zhu X, Yi X
The Science of the total environment 2020 Oct 15;739:139923
The Science of the total environment 2020 Oct 15;739:139923
Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Jin E, Wang W, Fang M, Wang W, Xie R, Zhou H, Ye J, Xu R, Ma S
Oncology letters 2019 Jan;17(1):502-507
Oncology letters 2019 Jan;17(1):502-507
Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
Jin E, Wang W, Fang M, Wang L, Wu K, Zhang Y, Zhang S, Ma S
Molecular medicine reports 2017 Nov;16(5):6382-6388
Molecular medicine reports 2017 Nov;16(5):6382-6388
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Transfected HEK-293 cells were subjected to SDS PAGE followed by western blot with 10309-1-AP( GPRC5A,RAI3 Antibody) at dilution of 1:700
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human breast cancer using 10309-1-AP(GPRC5A,RAI3 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The GPRC5A,RAI3 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human GPRC5A,RAI3. This antibody recognizes human antigen. The GPRC5A,RAI3 antibody has been validated for the following applications: ELISA, IHC, WB analysis.